Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1ZVS

Crystal structure of the first class MHC mamu and Tat-Tl8 complex

Summary for 1ZVS
Entry DOI10.2210/pdb1zvs/pdb
DescriptorMHC class I antigen, Beta-2-microglobulin, Tat-Tl8, ... (4 entities in total)
Functional Keywordsthe first class mhc, mamu, tat-tl8, immune system
Biological sourceMacaca mulatta (rhesus monkey)
More
Total number of polymer chains6
Total formula weight89431.03
Authors
Lou, Z.,Chu, F.,Gao, G.F.,Rao, Z. (deposition date: 2005-06-02, release date: 2006-06-13, Last modification date: 2024-11-20)
Primary citationChu, F.,Lou, Z.,Chen, Y.W.,Liu, Y.,Gao, B.,Zong, L.,Khan, A.H.,Bell, J.I.,Rao, Z.,Gao, G.F.
First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.
J Immunol., 178:944-952, 2007
Cited by
PubMed Abstract: The infection of rhesus macaques (Macaca mulatta) by the SIV is the best animal model for studying HIV infection and for AIDS vaccine development. A prevalent MHC class I allele, Mamu-A*01, is known to correlate with containment of SIV, which has been extensively explored in studies of CTL-based vaccination concepts. We determined the crystal structures of Mamu-A*01 complexed with two immunodominant SIV epitopes: the nonamer CM9 of group-specific Ag (Gag, 181-189; CTPYDINQM) and the octamer TL8 of transcription activator (Tat, 28-35; TTPESANL). The overall structures of the two Mamu-A*01 complexes are similar to other MHC class I molecules. Both structures confirm the presence of an absolutely conserved proline anchor residue in the P3 position of the Ag, bound to a D pocket of the Mamu-A*01 H chain with optimal surface complementarity. Like other MHC/peptide complex structures, the P2 and C-terminal residues of the epitopes are also important for anchoring to the MHC molecule, whereas the middle residues form an arch and their side chains are directed into solvent. These two structures reveal details of how Mamu-A*01 interacts with two well-studied epitopes at the atomic level. We discuss the structural basis of CTL escape, based on molecular models made possible by these two structures. The results we present in this study are most relevant for the rational design of Mamu-A*01-restricted CTL epitopes with improved binding, as a step toward development of AIDS vaccines.
PubMed: 17202356
DOI: 10.4049/jimmunol.178.2.944
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon